What's The BUZZ?

Market News, Products, Services, and Trends

SoftWriters Announces Partnership with Advasur

Relationship Will Aid Long-Term Care Pharmacies in Regulatory Compliance 


PITTSBURGH, May 8, 2023 –– SoftWriters, Inc., the industry leader in long-term care (LTC) pharmacy software, is excited to partner with Advasur360, a comprehensive suite of Drug Supply Chain Security Act services.  


At SoftWriters, our mission is to save lives. We provide software solutions for the entire long-term care pharmacy ecosystem. Advasur was formed to ensure pharmacists meet compliance requirements by providing a turnkey, outsourced series of systems and services to allow pharmacy teams to ensure their supplier’s products are safe and effective for their patients while protecting their practice.   


This partnership comes with the approaching deadline of the federal mandate of the Drug Supply Chain Security Act (DSCSA). The enforcement of all current requirements, including the last three requirements of Enhanced Distribution Security, takes effect on November 27, 2023. With the accelerated rush to compliance, SoftWriters and Advasur strive to help pharmacies take the necessary action steps while avoiding risks along the way. Read more >


SoftWriters

SoftWriters News & Announcements

SoftWriters is on a mission to save lives. As a pioneer and market leader in long-term care pharmacy technology, we are proud to help pharmacies at all stages of growth deliver better patient outcomes and experiences. We streamline the pharmacy process to help you compete effectively, grow efficiently, and maximize margin.

10-rxinsider-staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

This post is related to:

SUBSCRIBE

Please enable JavaScript in your browser to complete this form.
Name
Subscription Choices
Checkboxes

Request information from SoftWriters Announces Partnership with Advasur

Please enable JavaScript in your browser to complete this form.
Name
Address
Subscribe